Prostate enzyme may lead to better cancer imaging

June 20, 2013

A prostate enzyme called PSMA produced in higher quantities by prostate cancer cells may be the key to better prostate cancer screenings, according to a new study presented at the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting in Vancouver this week.

Approximately 29,700 men are expected to die of prostate cancer this year alone, and 238,600 patients will be newly diagnosed with prostate cancer, according to 2013 data from the American Cancer Society.